A.R.T. Advisors’s Alimera Sciences ALIM Stock Holding History

A.R.T. Advisors’s Portfolio ALIM Stock Details ALIM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-2,811	Closed	-$43K	–	1820
2018 Q1	$43K	Buy	+2,811	New	+$49.9K	﹤0.01%	1410
2017 Q3	–	Sell	-5,539	Closed	-$115K	–	1734
2017 Q2	$115K	Buy	+5,539	New	+$119K	0.01%	1239
2016 Q1	–	Sell	-1,482	Closed	-$53K	–	1702
2015 Q4	$53K	Buy	+1,482	New	+$64.3K	﹤0.01%	1380

Other funds holding ALIM

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ACP

Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

A.R.T. Advisors's ALIM Position: Q2 2018 in Review

A.R.T. Advisors sold out of Alimera Sciences (ALIM) in Q2 2018, closing a stake of 2,811 shares — an estimated $43K sold.

A.R.T. Advisors first reported a position in ALIM in Q4 2015 and held it in 3 quarters. The position peaked at $115K in Q2 2017. 37 funds tracked by Wall St. Rank hold ALIM as of Q2 2018.

A.R.T. Advisors reported no remaining Alimera Sciences position as of Q2 2018 after selling out during the quarter.
A.R.T. Advisors sold 2,811 Alimera Sciences shares in Q2 2018, an estimated $43K.
A.R.T. Advisors first reported a position in Alimera Sciences in Q4 2015 and held it in 3 quarters.
A.R.T. Advisors's Alimera Sciences position peaked at $115K in Q2 2017.
37 funds tracked by Wall St. Rank held Alimera Sciences as of Q2 2018.

Based on A.R.T. Advisors's 13F filing for Q2 2018, filed 14 Aug 2018.